The Menopause Product Gap
For most of the twentieth century, menopause was treated as a medical event to be managed, not a life stage to be supported with well-designed products. The absorbent care aisle had period products for younger women and incontinence products for older ones, with almost nothing addressing the specific, overlapping needs of the years in between. Skincare largely ignored hormonal skin changes. The entire category was, for decades, a quiet gap in the market.
That's changing. And the pace of change is accelerating in ways that make this one of the more interesting areas in femtech product development right now.
What's Actually Driving the Shift
Demographics matter here. According to the Menopause Society, there are more than 50 million postmenopausal women in the US, with millions more currently in perimenopause — putting the combined figure somewhere in the range of 55 million or higher, depending on how perimenopause onset is defined. That population will keep growing: the oldest millennials (born in the early 1980s) are now in their early forties and approaching the typical perimenopause window, and Gen X women are moving through it in large numbers right now. These are women who grew up expecting personalized, well-designed products across every other category of their lives. They're not going to accept a product that treats their body as an afterthought.
But beyond the numbers, there's something cultural happening. Menopause is being talked about openly in ways it simply wasn't ten years ago. That openness has created both consumer demand and commercial permission for brands to develop and market products that address symptoms directly, without euphemism. Brands that build genuine technical competence in this space now have a real opportunity.
The Technical Complexity Brands Often Underestimate
Menopause product development looks deceptively simple from the outside. On closer inspection, it involves some genuinely tricky technical and regulatory challenges.
Take absorbent products. Perimenopausal women often experience both menstrual irregularity and light urinary leakage simultaneously. A product that works for one doesn't necessarily work for the other. Fluid viscosity, odor management chemistry, and fit all behave differently depending on what the product is managing. Designing an absorbent product that handles both with discretion, comfort, and dignity requires careful materials selection and significant testing. The nonwovens, absorbent core structures, and acquisition layers used in menstrual products are not simply interchangeable with those developed for incontinence applications.
Skincare is equally nuanced. Declining estrogen affects the skin's collagen density, barrier function, and moisture retention. Formulations that perform beautifully on younger skin can behave unpredictably on hormonally changing skin. An effective menopause skincare product isn't just a regular moisturizer with different marketing; it needs to be genuinely formulated for altered skin physiology. That means ingredient selection, stability testing, and claims substantiation all require specific attention. Brands operating in this space also need to understand cosmetics GMP requirements under ISO 22716, particularly if they're distributing in both the US and EU markets, where regulatory expectations around claims and safety documentation differ.
Thermal management is another area of growing interest. Night sweats and hot flashes are among the most reported and most disruptive menopause symptoms, yet moisture-wicking sleepwear and bedding products are still mostly generic. There's real room for product development that takes the specific thermal and moisture dynamics of vasomotor symptoms seriously, rather than simply applying athletic-wear technology to a different context.
Where the Most Interesting Development Is Happening
A few areas are worth watching closely.
Wipes and cleansing formats designed for vaginal comfort and pH balance during and after menopause are an emerging subcategory. This sits at the intersection of wet wipes and intimate care, and it requires careful formulation work. pH considerations, preservative systems, and material compatibility all need to be addressed rigorously. Sustainable and biodegradable substrate options are increasingly expected by consumers in this demographic, so the material sourcing conversation usually happens early.
Supplements and ingestibles for symptom support are growing fast, though the regulatory landscape for claims in this area is particularly important to navigate carefully, especially in the US and EU.
Color cosmetics formulated for mature skin are also developing more traction. Foundations that account for drier, less elastic skin, or products that address the redness and flushing that can accompany perimenopause, represent a genuine opportunity for beauty brands that invest in the right formulation expertise.
What Brands Need to Get Right
The brands doing this well share a few things in common. They treat menopause consumers as intelligent adults. They invest in genuine clinical and technical rigor rather than relying on lifestyle marketing to carry the product. And they approach regulatory and safety documentation as foundational, not as a later-stage consideration.
Entering this category without understanding the specific material requirements, formulation demands, and relevant standards is a fast route to a product that underdelivers. Consumers who've waited this long for products designed specifically for them are more discerning, not less.
The menopause category is finally getting serious attention from the R&D side of the industry. For brands prepared to do the technical work properly, the timing has rarely been better.
If you're developing a product in this space and want to talk through the technical side, Crown Abbey works with brands across menstrual, menopause, incontinence, skincare, and wipes categories to get from concept to market with the right materials, manufacturing partners, and regulatory groundwork in place. Get in touch to start the conversation.
← Back to Blog